Immediate Impact
2 standout
Citing Papers
Hyperuricemia and its related diseases: mechanisms and advances in therapy
2024 Standout
Signaling pathways in rheumatoid arthritis: implications for targeted therapy
2023 Standout
Works of O. A. Кislyak being referenced
Consensus on patients with hyperuricemia and high cardiovascular risk treatment: 2022
2022
Evaluation of a 12-week allopurinol-lowering therapy in combination with the non-steroidal anti-inflammatory drug meloxicam in patients with gout
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| O. A. Кislyak | 12 | 10 | 8 | 20 | 34 | |
| А.Н. Цыгин | 5 | 12 | 4 | 14 | 48 | |
| Asma Mousavi | 21 | 21 | 3 | 20 | 71 | |
| William Davison | 18 | 12 | 3 | 15 | 61 | |
| Noor Alicezah Mohd Kasim | 44 | 8 | 6 | 35 | 165 | |
| Ana B. Serrano | 23 | 4 | 2 | 16 | 52 | |
| М. А. Магомедов | 6 | 16 | 2 | 27 | 44 | |
| Makoto Takatori | 8 | 9 | 2 | 20 | 44 | |
| Syed Sarmad Javaid | 20 | 7 | 19 | 71 | ||
| Lihua Wu | 5 | 6 | 9 | 50 | ||
| Bahar Darouei | 22 | 8 | 17 | 60 |
All Works
Login with ORCID to disown or claim papers
Loading papers...